Manage episode 354868446 series 3276400
According to Dr. Joel M. Zinberg, physician and health care expert, one such issue is the practice of medicine, as a nineteen-line section relating to the authority of the Food & Drug Administration (FDA) may fundamentally change the future viability of off-label prescriptions. Dr. Zinberg joins us in this podcast to explain the Act’s provisions concerning the FDA, the possible implications on the practice of medicine, and possible solutions to the potential pitfalls posed by these new health care provisions.
- Joel Zinberg, Senior Fellow, Competitive Enterprise Institute
As always, the Federalist Society takes no position on particular legal or public policy issues; all expressions of opinion are those of the speaker.